LAT PHARMA
LAT Pharma was founded with a mission to invent, develop, and commercialize therapies for people suffering from advanced liver cirrhosis and its life-threatening complications. The company's initial disease target is ascites due to liver cirrhosis. Patients with ascites face a very poor prognosis and there are no effective drug therapies for the latter stages of this disease. Liver cirrhosis and related complications are the 12th leading cause of death due to disease in the US, killing an estimated 27,000 people each year. In addition to its pre-IND new drug candidate, the company has a collaboration with PharmaIN Corporation (Bothell, WA) to develop novel compounds for liver diseases.
LAT PHARMA
Industry:
Biotechnology Life Science Therapeutics
Founded:
2006-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.lat-pharma.com
Total Employee:
1+
Status:
Closed
Technology used in webpage:
Domain Not Resolving
